Publications by authors named "Peter Blasko"

Claim this Profile
3
30-Day Outcomes of Real-World Elective Carotid Stenosis Treatment Using a Dual-Layer Micromesh Stent (ROADSAVER Study).
Ralf Langhoff, Zsolt Vajda, Piotr Odrowąż-Pieniążek, Aleksandar Gjoreski, Roel Beelen

Cardiovasc Intervent Radiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth?
Peter Blaško, Matej Samoš, Tomáš Bolek, Lucia Stančiaková, Ingrid Škorňová

J Clin Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction: the COOL AMI EU Pivotal Trial.
Marko Noc, Peep Laanmets, Aleksandar N Neskovic, Milovan Petrović, Bojan Stanetic, Peter Blasko

EuroIntervention· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of polymorphisms of platelet receptors GPIa (807C>T), GPVI (13254T>C), and P2Y12 (34C>T and H1/H2 haplotype) with increased risk of periprocedural bleeding in patients undergoing coronary angiography/percutaneous coronary intervention.
Magdalena Sionova, Peter Blasko, Stepan Jirous, David Vindis, Richard Rokyta

Postepy Kardiol Interwencyjnej· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Number of severe bleeding complications according to classification used: Is unified classification of bleeding complications really necessary?
Magdalena Sionova, Peter Blasko, Stepan Jirous, David Vindis, Richard Rokyta

Cardiol J· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of occult paroxysmal atrial fibrilation by implantable long-term electrocardiographic monitoring in cryptogenic stroke and transient ischemic attack population: a study protocol for prospective matched cohort study.
Andrea Petrovičová, Egon Kurča, Miroslav Brozman, Jozef Hasilla, Pavel Vahala

BMC Cardiovasc Disord· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial).
Petr Ostadal, David Alan, Jiri Vejvoda, Jiri Kukacka, Milan Macek, Peter Blasko

Trials· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate effect of fluvastatin on lipid levels in acute coronary syndrome.
Petr Ostadal, David Alan, Jiri Vejvoda, Jana Cepova, Jiri Kukacka, Peter Blasko

Mol Cell Biochem· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thirty-day outcomes of direct carotid artery stenting with cerebral protection in high-risk patients.
Josef Veselka, Daniela Cerná, Petra Zimolová, Peter Blasko, Jirí Fiedler

Circ J· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696].
Petr Ostadal, David Alan, Petr Hajek, Jiri Vejvoda, Martin Mates, Peter Blasko

Curr Control Trials Cardiovasc Med· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis